Alpron | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Alpron
Canada

PharmaCompass Sponsored Ads

Contact Supplier

European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

Contact Supplier

pharmacompass-1-m-2026-01-12

Evonik Health Care is the innovation hub for leading life science companies

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

pharmacompass-2-2026-02-09

Alpron

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

71 API Suppliers, 23 USDMF, 12 CEP/COS, 1 JDMF, 3 EU WC, 31 KDMF, 12 NDC API, 1 VMF, 17 Listed Suppliers, $ API Reference Price

71 API Suppliers
23 USDMF
12 CEP/COS
1 JDMF
3 EU WC
31 KDMF
12 NDC API
1 VMF
17 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

24 Drugs in Development

24 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

404 FDF Dossiers, 116 FDA Orange Book, 161 Europe, 25 Canada, 25 Australia, 25 South Africa, 52 Listed Dossiers

404 FDF Dossiers
116 FDA Orange Book
161 Europe
25 Canada
25 Australia
25 South Africa
52 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 250MG, TABLET;ORAL - 375MG, TABLET;ORAL - 500MG, SUSPENSION;ORAL - 25MG/ML, TABLET, DELAYED RELEASE;ORAL - 375MG, TABLET, DELAYED RELEASE;ORAL - 500MG, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 250MG
TABLET;ORAL - 375MG
TABLET;ORAL - 500MG
SUSPENSION;ORAL - 25MG/ML
TABLET, DELAYED RELEASE;ORAL - 375MG
TABLET, DELAYED RELEASE;ORAL - 500MG
TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

7 Evonik, 1 Rochem International Inc, 6 SPI Pharma, 11 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Kirsch Pharma, 1 ACG Worldwide, 8 Actylis, 2 Aeon Procare, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 33 BASF, 1 CD Formulation, 1 Clariant, 14 Corel Pharma Chem, 6 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 12 Gangwal Chemicals, 12 Ideal Cures, 4 Ingredion Pharma Solutions, 20 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 27 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 3 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

66 Coating Systems & Additives, 61 Fillers, Diluents & Binders, 39 Disintegrants & Superdisintegrants, 37 Controlled & Modified Release, 36 Solubilizers, 30 Granulation, 30 Direct Compression, 30 Thickeners and Stabilizers, 23 Film Formers & Plasticizers, 20 Taste Masking, 18 Topical, 17 Parenteral, 17 Lubricants & Glidants, 15 Co-Processed Excipients, 13 Chewable & Orodispersible Aids, 7 Emulsifying Agents, 6 Surfactant & Foaming Agents, 6 API Stability Enhancers, 5 Empty Capsules, 5 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

66 Coating Systems & Additives
61 Fillers, Diluents & Binders
39 Disintegrants & Superdisintegrants
37 Controlled & Modified Release
36 Solubilizers
30 Granulation
30 Direct Compression
30 Thickeners and Stabilizers
23 Film Formers & Plasticizers
20 Taste Masking
18 Topical
17 Parenteral
17 Lubricants & Glidants
15 Co-Processed Excipients
13 Chewable & Orodispersible Aids
7 Emulsifying Agents
6 Surfactant & Foaming Agents
6 API Stability Enhancers
5 Empty Capsules
5 Rheology Modifiers
4 Vegetarian Capsules
2 Coloring Agents
1 Soft Gelatin

DIGITAL CONTENT

39 News #PharmaBuzz

39 News #PharmaBuzz

GLOBAL SALES INFORMATION

20 US Medicaid Prescriptions, 42 Regulatory FDF Prices, 2 Annual Reports

20 US Medicaid Prescriptions
42 Regulatory FDF Prices
2 Annual Reports

MARKET PLACE

35 APIs, 3 FDF Dossiers

35 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 Health Canada Patents

8 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 41 Others

3 EDQM
41 Others

ANALYTICAL

3 BioAnalytical Methods

3 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 34 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

25 All

01 2Orion Corporation

02 6APOTEX INC

03 1MEDEXUS PHARMACEUTICALS INC.

04 2MYLAN PHARMACEUTICALS ULC

05 1PRO DOC LIMITEE

06 3Pharmascience Inc.

07 2SEARCHLIGHT PHARMA INC

08 6TEVA CANADA LIMITED

09 2XEDITON PHARMACEUTICALS INC

filter Active Ingredients Reset all filters

25 All

01 20NAPROXEN

02 5Naproxen

filter Dosage Form Reset all filters

25 All

01 2ORAL SUSPENSION

02 1SUPPOSITORY

03 1SUSPENSION

04 6TABLET

05 1TABLET (DELAYED-RELEASE)

06 9TABLET (ENTERIC-COATED)

07 1TABLET (EXTENDED-RELEASE)

08 4TABLET (IMMEDIATE AND DELAYED-RELEASE)

filter Brand Name Reset all filters

25 All

01 3APO-NAPROXEN

02 2APO-NAPROXEN EC

03 1APO-NAPROXEN EC TABLETS

04 2MYLAN-NAPROXEN/ESOMEPRAZOLE MR

05 2NAPROSYN

06 1PEDIAPHARM NAPROXEN SUSPENSION

07 1PMS-NAPROXEN

08 2PMS-NAPROXEN EC

09 1PRO-NAPROXEN EC

10 3TEVA-NAPROXEN

11 3TEVA-NAPROXEN EC

12 2VIMOVO

13 2Blank

List of Suppliers

Product Main Page

01

Orion Corporation

International Sweetener Colloquium

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info : Generic

Registration Country : Canada

Brand Name :

Dosage Form : ORAL SUSPENSION

Dosage Strength : 100ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Canada

Fermion Orion Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Orion Corporation

International Sweetener Colloquium

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info : Generic

Registration Country : Canada

Brand Name :

Dosage Form : ORAL SUSPENSION

Dosage Strength : 200ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Canada

Fermion Orion Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

APOTEX INC

International Sweetener Colloquium

Not Confirmed

APOTEX INC

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : APO-NAPROXEN

Dosage Form : TABLET

Dosage Strength : 250MG

Packaging : 100/1000

Approval Date :

Application Number : 522651

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

APOTEX INC

International Sweetener Colloquium

Not Confirmed

APOTEX INC

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : APO-NAPROXEN

Dosage Form : TABLET

Dosage Strength : 500MG

Packaging : 100/500

Approval Date :

Application Number : 592277

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

APOTEX INC

International Sweetener Colloquium

Not Confirmed

APOTEX INC

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : APO-NAPROXEN

Dosage Form : TABLET

Dosage Strength : 375MG

Packaging : 100/500

Approval Date :

Application Number : 600806

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

APOTEX INC

International Sweetener Colloquium

Not Confirmed

APOTEX INC

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : APO-NAPROXEN EC TABLETS

Dosage Form : TABLET (ENTERIC-COATED)

Dosage Strength : 250MG

Packaging : 100

Approval Date :

Application Number : 2246699

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

APOTEX INC

International Sweetener Colloquium

Not Confirmed

APOTEX INC

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : APO-NAPROXEN EC

Dosage Form : TABLET (ENTERIC-COATED)

Dosage Strength : 375MG

Packaging : 100

Approval Date :

Application Number : 2246700

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

APOTEX INC

International Sweetener Colloquium

Not Confirmed

APOTEX INC

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : APO-NAPROXEN EC

Dosage Form : TABLET (ENTERIC-COATED)

Dosage Strength : 500MG

Packaging : 100

Approval Date :

Application Number : 2246701

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

MEDEXUS PHARMACEUTICALS INC.

International Sweetener Colloquium

Not Confirmed

MEDEXUS PHARMACEUTICALS INC.

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : PEDIAPHARM NAPROXEN SUSPENSION

Dosage Form : SUSPENSION

Dosage Strength : 25MG/ML

Packaging : 474ML

Approval Date :

Application Number : 2162431

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

MYLAN PHARMACEUTICALS ULC

International Sweetener Colloquium

Not Confirmed

MYLAN PHARMACEUTICALS ULC

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : MYLAN-NAPROXEN/ESOMEPRAZOLE MR

Dosage Form : TABLET (IMMEDIATE AND DELAYED-RELEASE)

Dosage Strength : 500MG

Packaging : 60/100/500

Approval Date :

Application Number : 2443449

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.